02.06.2021 • NewsLanxess

Lanxess Closes Sale of Organic Leather Chemicals Unit

Following all approvals, German specialty chemicals producer Lanxess completed the sale of its organic leather chemicals business to TFL Ledertechnik on Jun. 1. The buyer is a global supplier of leather chemicals and a portfolio company of US private equity investor Black Diamond Capital Management.

The deal agreed in August last year includes all operations of the organic leather chemicals business line with around 420 employees. TFLs is paying a fixed sum of €80 million. A second component leverages a trade working capital mechanism that foresees a payment of around EUR 20 million in the 2021 third quarter. Thirdly, the purchase price includes a performance-related component of up to €115 million, to be paid out over the next three years. TFL also is assuming “certain liabilities.”

With the closing, Lanxess is finally exiting the leather chemicals field. In January 2020, it divested its chrome chemicals business and at the end of 2019 agreed to sell its stake in the related South African chrome ore mine. Since the end of 2019, that time, the Cologne-based chemicals and plastics producer has reported the leather business unit as a discontinued operation.

Author: Dede Williams, Freelance Journalist

German specialty chemicals producer Lanxess closed the sale of its organic...
German specialty chemicals producer Lanxess closed the sale of its organic leather chemicals business to TFL Ledertechnik on Jun. 1. The buyer, a global supplier of leather chemicals, is a portfolio company of US private equity investor Black Diamond Capital Management. (c) Lanxess

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.